In summary, we found and provided evidence that CARM1 inhibited ferroptosis, which is closely related to ACSL4 R339 methylation, and that its inhibitor suppressed tumor progression when combined with anti‐PD‐1. The gene discussed is ACSL4; the disease is neoplasm.